Ironwood Pharmaceuticals reported $583.99M in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Acadia Pharmaceuticals USD 56.29M 1.36M Jun/2025
Agios Pharmaceuticals USD 48.76M 47.62M Jun/2025
Alnylam Pharmaceuticals USD 1.3B 271.5M Jun/2025
Amarin USD 0 0 Mar/2025
Ardelyx USD 207.61M 968K Sep/2025
Astellas Pharma JPY 831.43B 83.94B Mar/2025
AstraZeneca USD 32.84B 1.19B Jun/2025
Charles River Laboratories USD 2.79B 74.83M Jun/2025
Exact Sciences USD 2.34B 15.24M Sep/2025
Halozyme Therapeutics USD 1.51B 1.65M Jun/2025
Incyte USD 42.41M 5.29M Jun/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
MacroGenics USD 37.01M 238K Sep/2025
Moderna USD 741M 4M Jun/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Pacira USD 376.72M 203.77M Sep/2025
PTC Therapeutics USD 286.32M 306K Sep/2025
Sarepta Therapeutics USD 1.35B 215.59M Jun/2025
Takeda JPY 4.85T 208B Dec/2025
Ultragenyx Pharmaceutical USD 36.3M 1.98M Jun/2025